Cogent Biosciences, Inc.
NASDAQ:COGT
10.21 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -192.41 | -140.241 | -72.273 | -74.808 | -31.833 | -34.532 | -25.492 | -18.124 | -6.592 |
| Depreciation & Amortization
| 3.588 | 5.878 | 0.147 | 0.72 | 1.293 | 1.321 | 1.171 | 0.83 | 0.179 |
| Deferred Income Tax
| -4.813 | 0 | 0 | -7.493 | 0 | -0.236 | 0.017 | 0.017 | -0.248 |
| Stock Based Compensation
| 30.621 | 18.368 | 11.686 | 6.017 | 3.241 | 3.088 | 1.341 | 1.016 | 0.248 |
| Change In Working Capital
| 11.442 | 0.751 | 2.02 | -5.316 | -14.084 | -2.153 | -2.879 | -2.323 | 23.881 |
| Accounts Receivables
| 0 | 0 | 0 | 2 | -0.332 | -0.838 | 0.098 | -0.634 | -0.294 |
| Inventory
| 0 | 0 | 0 | -3.55 | 1.218 | 2.214 | 0.931 | 0.784 | 0.22 |
| Accounts Payables
| 4.813 | 2.359 | 2.751 | -2.451 | 1.664 | 0.367 | -0.031 | 0.389 | 0.705 |
| Other Working Capital
| -4.813 | -1.608 | -0.731 | -1.315 | -16.634 | -3.896 | -3.877 | -2.862 | 23.25 |
| Other Non Cash Items
| -2.052 | -3.394 | -0.343 | 45.03 | -0.131 | 0.023 | 0.007 | -0.056 | 0.248 |
| Operating Cash Flow
| -153.624 | -118.638 | -58.763 | -35.85 | -41.514 | -32.489 | -25.835 | -18.64 | 17.716 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -2.796 | -6.863 | -1.719 | 0 | -0.033 | -0.549 | -0.912 | -3.307 | -1.994 |
| Acquisitions Net
| 0.095 | 0.118 | 0 | 8.42 | 0.204 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -348.803 | -177.855 | 0 | 0 | -0.204 | -47.682 | -6.5 | -55.172 | 0 |
| Sales Maturities Of Investments
| 253.775 | 60 | 0 | 0 | 22.988 | 37.7 | 21 | 28 | 0 |
| Other Investing Activites
| -0.095 | -0.118 | 0 | 0.008 | 0.204 | 0 | -0.075 | 0.05 | -1.255 |
| Investing Cash Flow
| -97.824 | -124.718 | -1.719 | 8.42 | 23.159 | -10.531 | 13.513 | -30.429 | -3.249 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 163.536 | 163.558 | 38.006 | 132.729 | 0.108 | 71.793 | 0.06 | 0 | 70.752 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.164 | 0.164 | -0.03 | 99.467 | 0 | -1.447 | -0.789 | -0.04 | 70.752 |
| Financing Cash Flow
| 163.536 | 163.558 | 37.976 | 232.196 | 0.108 | 70.346 | -0.729 | -0.04 | 70.752 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -87.912 | -79.798 | -22.506 | 204.766 | -18.247 | 27.326 | -13.051 | -49.109 | 85.219 |
| Cash At End Of Period
| 53.229 | 141.141 | 220.939 | 243.445 | 38.679 | 56.926 | 28.27 | 41.321 | 90.43 |